Anticancer researchHumansCisplatinCaffeic AcidsPhenylethyl AlcoholCarcinoma
Combined Treatment of Cisplatin With Caffeic Acid Phenethyl Ester Demonstrates Additive Growth Inhibition on Non-small Cell Lung Cancer Cells.
Ching-Yi Lee, Yu-Ke Fu, Chien-Chih Yeh, Li-Kuo Kuo, Ying-Yu Kuo, Chieh Huo, Shih-Wei Lee, Yung-Chia Huang, Li-Jane Shih, Chia-Yang Li, Shu-Pin Huang, Chih-Jen Lai, Chih-Pin Chuu
Published: 202510.21873/anticanres.17840
Abstract
BACKGROUND/AIM: Non-small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancer cases. While cisplatin remains standard treatment for NSCLC, development of drug resistance causes failure of treatment. Caffeic acid phenethyl ester…
Preview only. Read the full abstract at the source